Neurogenic orthostatic hypotension (also referred to as neurogenic OH or nOH) is a rare disorder that is defined as low blood pressure that occurs upon standing. NOH is a sub-type of orthostatic hypotension (OH). With NOH and other forms of orthostatic hypotension, patients experience the same symptoms but for different reasons. NOH only occurs in people with an existing neurologic disease, such as: Multiple system atrophy (MSA), Parkinson's disease, Pure autonomic failure (PAF), Diabetic neuropathy, Dopamine beta hydroxylase (DBH) deficiency.
This report elaborates the market size, market characteristics, and market growth of the Neurogenic Orthostatic Hypotension industry, and breaks down according to the type, application, and consumption area of Neurogenic Orthostatic Hypotension. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Neurogenic Orthostatic Hypotension in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Neurogenic Orthostatic Hypotension market covered in Chapter 13:
Sumitomo Pharmaceuticals
NORTHERA? (Droxidopa)
Shire PLC (ProAmatine?)
Chelsea Therapeutics (Droxidopa)
In Chapter 6, on the basis of types, the Neurogenic Orthostatic Hypotension market from 2015 to 2025 is primarily split into:
Parkinson's disease
Diabetes
Dopamine beta hydroxylase (DBH) deficiency
MSA
PAF
Others
In Chapter 7, on the basis of applications, the Neurogenic Orthostatic Hypotension market from 2015 to 2025 covers:
Clinic
Hospital
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Neurogenic Orthostatic Hypotension Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Neurogenic Orthostatic Hypotension Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Neurogenic Orthostatic Hypotension Market Forces
3.1 Global Neurogenic Orthostatic Hypotension Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Neurogenic Orthostatic Hypotension Market - By Geography
4.1 Global Neurogenic Orthostatic Hypotension Market Value and Market Share by Regions
4.1.1 Global Neurogenic Orthostatic Hypotension Value ($) by Region (2015-2020)
4.1.2 Global Neurogenic Orthostatic Hypotension Value Market Share by Regions (2015-2020)
4.2 Global Neurogenic Orthostatic Hypotension Market Production and Market Share by Major Countries
4.2.1 Global Neurogenic Orthostatic Hypotension Production by Major Countries (2015-2020)
4.2.2 Global Neurogenic Orthostatic Hypotension Production Market Share by Major Countries (2015-2020)
4.3 Global Neurogenic Orthostatic Hypotension Market Consumption and Market Share by Regions
4.3.1 Global Neurogenic Orthostatic Hypotension Consumption by Regions (2015-2020)
4.3.2 Global Neurogenic Orthostatic Hypotension Consumption Market Share by Regions (2015-2020)
5 Neurogenic Orthostatic Hypotension Market - By Trade Statistics
5.1 Global Neurogenic Orthostatic Hypotension Export and Import
5.2 United States Neurogenic Orthostatic Hypotension Export and Import (2015-2020)
5.3 Europe Neurogenic Orthostatic Hypotension Export and Import (2015-2020)
5.4 China Neurogenic Orthostatic Hypotension Export and Import (2015-2020)
5.5 Japan Neurogenic Orthostatic Hypotension Export and Import (2015-2020)
5.6 India Neurogenic Orthostatic Hypotension Export and Import (2015-2020)
5.7
6 Neurogenic Orthostatic Hypotension Market - By Type
6.1 Global Neurogenic Orthostatic Hypotension Production and Market Share by Types (2015-2020)
6.1.1 Global Neurogenic Orthostatic Hypotension Production by Types (2015-2020)
6.1.2 Global Neurogenic Orthostatic Hypotension Production Market Share by Types (2015-2020)
6.2 Global Neurogenic Orthostatic Hypotension Value and Market Share by Types (2015-2020)
6.2.1 Global Neurogenic Orthostatic Hypotension Value by Types (2015-2020)
6.2.2 Global Neurogenic Orthostatic Hypotension Value Market Share by Types (2015-2020)
6.3 Global Neurogenic Orthostatic Hypotension Production, Price and Growth Rate of Parkinson's disease (2015-2020)
6.4 Global Neurogenic Orthostatic Hypotension Production, Price and Growth Rate of Diabetes (2015-2020)
6.5 Global Neurogenic Orthostatic Hypotension Production, Price and Growth Rate of Dopamine beta hydroxylase (DBH) deficiency (2015-2020)
6.6 Global Neurogenic Orthostatic Hypotension Production, Price and Growth Rate of MSA (2015-2020)
6.7 Global Neurogenic Orthostatic Hypotension Production, Price and Growth Rate of PAF (2015-2020)
6.8 Global Neurogenic Orthostatic Hypotension Production, Price and Growth Rate of Others (2015-2020)
7 Neurogenic Orthostatic Hypotension Market - By Application
7.1 Global Neurogenic Orthostatic Hypotension Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Neurogenic Orthostatic Hypotension Consumption by Applications (2015-2020)
7.1.2 Global Neurogenic Orthostatic Hypotension Consumption Market Share by Applications (2015-2020)
7.2 Global Neurogenic Orthostatic Hypotension Consumption and Growth Rate of Clinic (2015-2020)
7.3 Global Neurogenic Orthostatic Hypotension Consumption and Growth Rate of Hospital (2015-2020)
8 North America Neurogenic Orthostatic Hypotension Market
8.1 North America Neurogenic Orthostatic Hypotension Market Size
8.2 United States Neurogenic Orthostatic Hypotension Market Size
8.3 Canada Neurogenic Orthostatic Hypotension Market Size
8.4 Mexico Neurogenic Orthostatic Hypotension Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Neurogenic Orthostatic Hypotension Market Analysis
9.1 Europe Neurogenic Orthostatic Hypotension Market Size
9.2 Germany Neurogenic Orthostatic Hypotension Market Size
9.3 United Kingdom Neurogenic Orthostatic Hypotension Market Size
9.4 France Neurogenic Orthostatic Hypotension Market Size
9.5 Italy Neurogenic Orthostatic Hypotension Market Size
9.6 Spain Neurogenic Orthostatic Hypotension Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Neurogenic Orthostatic Hypotension Market Analysis
10.1 Asia-Pacific Neurogenic Orthostatic Hypotension Market Size
10.2 China Neurogenic Orthostatic Hypotension Market Size
10.3 Japan Neurogenic Orthostatic Hypotension Market Size
10.4 South Korea Neurogenic Orthostatic Hypotension Market Size
10.5 Southeast Asia Neurogenic Orthostatic Hypotension Market Size
10.6 India Neurogenic Orthostatic Hypotension Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Neurogenic Orthostatic Hypotension Market Analysis
11.1 Middle East and Africa Neurogenic Orthostatic Hypotension Market Size
11.2 Saudi Arabia Neurogenic Orthostatic Hypotension Market Size
11.3 UAE Neurogenic Orthostatic Hypotension Market Size
11.4 South Africa Neurogenic Orthostatic Hypotension Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Neurogenic Orthostatic Hypotension Market Analysis
12.1 South America Neurogenic Orthostatic Hypotension Market Size
12.2 Brazil Neurogenic Orthostatic Hypotension Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Sumitomo Pharmaceuticals
13.1.1 Sumitomo Pharmaceuticals Basic Information
13.1.2 Sumitomo Pharmaceuticals Product Profiles, Application and Specification
13.1.3 Sumitomo Pharmaceuticals Neurogenic Orthostatic Hypotension Market Performance (2015-2020)
13.2 NORTHERA